Drug intelligence / Profile preview

Zhenke Tangjiang

Development stage: Unknown
Lead developer: Yaodu Zhangshu Pharmaceutical
Modality: Small Molecules
Administration: Oral

Overview

Zhenke Tangjiang (Antitussive Syrup) is a traditional Chinese medicine (TCM) herbal formulation developed and manufactured by Yaodu Zhangshu Pharmaceutical, a subsidiary of the Renhe Group. Formulated as an oral syrup, it is primarily indicated for the symptomatic relief of cough. The preparation typically utilizes a blend of traditional Chinese herbs known for their demulcent, expectorant, and antitussive properties to soothe the respiratory mucosa and modulate the cough reflex. As an approved product in China, it is part of Yaodu Zhangshu Pharmaceutical's extensive portfolio of over 200 traditional medicine varieties and is marketed for general respiratory health and cough suppression.

Brand names: Renhe
Other names: Antitussive Syrup镇咳糖浆

Beyond the preview

Go deeper on Zhenke Tangjiang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zhenke Tangjiang.

Explore the full profile